Future Microbiology

Papers
(The H4-Index of Future Microbiology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Effect of Rapamycin on Cryptococcus Neoformans : Cellular Organization, Biophysics and Virulence Factors85
Predicting of novel homoserine dehydrogenase inhibitors against Paracoccidioides brasiliensis : integrating in silico and i76
First Report of Rhino-Orbital-Cerebral Mucormycosis After COVID-19 Infection in Bulgaria56
Therapeutic Potential of MiRNAS in Clostridioides Difficile Infection49
Propionylation of Fis K32 in Salmonella enterica serovar Typhi: a key modification affecting pathogenicity30
In vitro Activities of Antibiotic Combinations Against Mature Biofilms of Ventilator-Associated Pneumonia Isolates28
Natural Bioactives Versus Synthetic Antibiotics for the Attenuation of Quorum Sensing-Regulated Virulence Factors of Pseudomonas Aeruginosa24
Sources, transmission and hospital-associated outbreaks of nontuberculous mycobacteria: a review23
Inflammation at the Crossroads of Helicobacter Pylori and COVID-1920
Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment19
Repurposing Prokaryotic Clustered Regularly Interspaced Short Palindromic Repeats-Cas Adaptive Immune System to Combat Antimicrobial Resistance18
Cymbopogon Citratus Essential Oil: An Active Principle of Nanoemulsion Against Enterococcus Faecalis Root Canal Biofilm18
Hospital-Onset Bacteremia: Clinical and Regulatory Ramifications17
Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis17
Analysis of subgingival bacterial and fungal diversity in patients with peri-implantitis based on 16sRNA and internal transcribed spacer sequencing17
Roles of the components of the cag -pathogenicity island encoded type IV secretion system in Helicobacter pylori16
Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii16
0.12679314613342